Advertisement

Sun Capital Partners, Inc. Company Profile

20:47 EDT 18th May 2013 | BioPortfolio

Sun Capital Partners, Inc. is a leading private investment firm focused on leveraged buyouts, equity, debt, and other investments in companies that can benefit from its in–house operating professionals and experience. Sun Capital affiliates have invested in more than 295 companies worldwide with combined sales in excess of $45 billion since Sun Capital’s inception in 1995. Sun Capital has offices in Boca Raton, Los Angeles, and New York, as well as affiliates in London, Paris, Frankfurt, Luxembourg, Shanghai and Shenzhen. For more information, please visit www.SunCapPart.com.


News Articles [ 743 Associated News Articles listed on BioPortfolio]

Bay Bridge Capital Partners acquires Plum Healthcare Group

GI Partners ("GI"), a leading mid-market private equity firm, announced today the sale of its portfolio company, Plum Healthcare Group, LLC ("Plum"), one of the fastest growing companies in healthcare...

Endosense, SA: Series C $40.3M

Endosense (Switzerland), a commercial-stage medical device company focused on catheter ablation for cardiac arrhythmias, closed a $40.3M Series C financing. Participants included NGN Capital, Edmond d...

Bluebird Bio in series D financing for $60 million

bluebird bio announced the successful completion of a $60 million Series D financing. In this round, new investors Deerfield Partners, RA Capital, Ramius Capital Group, and two undisclosed blue chip p...

Interline Brands Announces Agreement to be Acquired by GS Capital Partners and P2 Capital Partners in Transaction Valued at $1.1 Billion

JACKSONVILLE, Fla., May 29, 2012 (GLOBE NEWSWIRE) -- Interline Brands, Inc. (NYSE:IBI) ("Interline" or the "Company"), a leading distributor and direct marketer of broad-line maintenance, repair and...

bluebird bio completes $60 million Series D financing

bluebird bio, a leader in the development of innovative gene therapies for severe genetic disorders, today announced the successful completion of a $60 million Series D financing. In this round, new i...

Capital Royalty announces $805m in royalty financing

Capital Royalty announced the final closing of Capital Royalty Partners II with $805 million in equity financing. Capital Royalty Partners II, the Firm’s second private equity fund, was oversubscrib...

GS Capital Partners VI Fund, L.P and P2 Capital Partners, LLC Complete Acquisition of Interline Brands, Inc.

NEW YORK, Sept. 7, 2012 (GLOBE NEWSWIRE) -- Interline Brands, Inc. (NYSE:IBI) (the "Company" or "Interline") today announced the completion of its acquisition by affiliates of Goldman Sachs Capital P...

Endosense secures $40.3 million Series C financing

Endosense has announced the close of a USD 40.3 million/CHF 37.4 million series C financing. Led by new investor NGN Capital, the round drew large participation from all existing investors, including...

PubMed Articles [ 507 Associated PubMed Articles listed on BioPortfolio]

Gay Men are Less Likely to Use Condoms with Casual Sex Partners They Know 'Well'

Health in Men (HIM) was an open cohort study of 1,427 HIV-negative homosexual men in Sydney. The majority of respondents' unprotected anal intercourse (UAIC) events were with partners whose HIV status...

Three cases of slipped capital femoral epiphysis in one family.

Slipped capital femoral epiphysis is a relatively common disorder of the hip that affects children in late childhood and early adolescence, with an incidence in the United States of approximately 10 p...

Social capital and physiological stress levels in free-ranging adult female rhesus macaques.

Social animals with greater access to social support, i.e. higher levels of social capital, may be able to cope better with the challenges they face in their day-to-day lives, and this may be reflecte...

Pain market.

FROM SOCIAL CAPITAL TO HEALTH - AND BACK.

We assess the causal relationship between health and social capital, measured by generalized trust, both at the individual and the community level. The paper contributes to the literature in two ways:...

Clinical Trials [ 113 Associated Clinical Trials listed on BioPortfolio]

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment

RATIONALE: Gathering information about survivors of prostate cancer and their partners may help doctors learn more about the goals for sexual functioning after cancer treatment. PURPOSE: T...

ID & Testing in Male Partners

This pilot study is a sub-study of ATN 067. ATN 067 utilizes a cross-sectional research design to recruit Latina and African American young women to undergo HIV screening. The primary goal...

Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer

RATIONALE: Telephone counseling after radical prostatectomy may help African American prostate cancer survivors and their intimate partners cope with the problems and challenges of surgery...

Companies [ 1468 Associated Companies listed on BioPortfolio]

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing....

Sun Capital Partners, Inc.

Sun Capital Partners, Inc. is a leading private investment firm focused on leveraged buyouts, equity, debt, and other investments in companies that can benefit from its in–ho...

Bindley Capital Partners

Bindley Capital Partners (BCP) is a private investment firm focused on the following activities:Acquiring or investing in outstanding private companies Co-investing with equity sponsors Committing cap...

More Information about "Sun Capital Partners, Inc." on BioPortfolio

We have published hundreds of Sun Capital Partners, Inc. news stories on BioPortfolio along with dozens of Sun Capital Partners, Inc. Clinical Trials and PubMed Articles about Sun Capital Partners, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sun Capital Partners, Inc. Companies in our database. You can also find out about relevant Sun Capital Partners, Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement